Xiaoting Hu

Array ( [id] => 4921515 [patent_doc_number] => 20080069830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Dna Sequences, Peptides, Antibodies and Vaccines for Prevention and Treatment of Sars' [patent_app_type] => utility [patent_app_number] => 10/562164 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7925 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069830.pdf [firstpage_image] =>[orig_patent_app_number] => 10562164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046450 [patent_doc_number] => 08541003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using' [patent_app_type] => utility [patent_app_number] => 10/873424 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 89 [patent_no_of_words] => 27303 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10873424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726742 [patent_doc_number] => 20080206283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Vaccine Against Sars' [patent_app_type] => utility [patent_app_number] => 10/561315 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16150 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206283.pdf [firstpage_image] =>[orig_patent_app_number] => 10561315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317493 [patent_doc_number] => 20040224311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Method for measuring anti-protease resistance of HIV-2 in a patient' [patent_app_type] => new [patent_app_number] => 10/865889 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4887 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224311.pdf [firstpage_image] =>[orig_patent_app_number] => 10865889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060988 [patent_doc_number] => 20050003349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'High titer recombinant influenza viruses for vaccines and gene therapy' [patent_app_type] => utility [patent_app_number] => 10/855875 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14262 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003349.pdf [firstpage_image] =>[orig_patent_app_number] => 10855875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 872707 [patent_doc_number] => 07361747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-22 [patent_title] => 'Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus' [patent_app_type] => utility [patent_app_number] => 10/852357 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 9 [patent_no_of_words] => 20726 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361747.pdf [firstpage_image] =>[orig_patent_app_number] => 10852357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7123210 [patent_doc_number] => 20050015039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein' [patent_app_type] => utility [patent_app_number] => 10/851637 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34141 [patent_no_of_claims] => 130 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20050015039.pdf [firstpage_image] =>[orig_patent_app_number] => 10851637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666573 [patent_doc_number] => 20060171923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Methods of identifying modulators of human retrovirus replication' [patent_app_type] => utility [patent_app_number] => 10/849567 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9341 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171923.pdf [firstpage_image] =>[orig_patent_app_number] => 10849567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823158 [patent_doc_number] => 07404956 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Immunoglobulin chimeric monomer-dimer hybrids' [patent_app_type] => utility [patent_app_number] => 10/841250 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 40 [patent_no_of_words] => 36926 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/404/07404956.pdf [firstpage_image] =>[orig_patent_app_number] => 10841250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930795 [patent_doc_number] => 20050281829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Fc chimeric proteins with anti-HIV drugs' [patent_app_type] => utility [patent_app_number] => 10/841956 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20018 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281829.pdf [firstpage_image] =>[orig_patent_app_number] => 10841956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 482167 [patent_doc_number] => 07220554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Methods for identifying inhibitors' [patent_app_type] => utility [patent_app_number] => 10/838770 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 32 [patent_no_of_words] => 42703 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220554.pdf [firstpage_image] =>[orig_patent_app_number] => 10838770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098570 [patent_doc_number] => 20050131029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Immunophilin ligand treatment of antiretroviral toxic neuropathy' [patent_app_type] => utility [patent_app_number] => 10/836517 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10171 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20050131029.pdf [firstpage_image] =>[orig_patent_app_number] => 10836517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402301 [patent_doc_number] => 20040175365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => new [patent_app_number] => 10/833439 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175365.pdf [firstpage_image] =>[orig_patent_app_number] => 10833439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341584 [patent_doc_number] => 20040191272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => new [patent_app_number] => 10/833745 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19897 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191272.pdf [firstpage_image] =>[orig_patent_app_number] => 10833745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820332 [patent_doc_number] => 07407661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Methods and reagents that generate a CD8 T cell immune response' [patent_app_type] => utility [patent_app_number] => 10/833744 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 41 [patent_no_of_words] => 19696 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407661.pdf [firstpage_image] =>[orig_patent_app_number] => 10833744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7018797 [patent_doc_number] => 20050220816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Mutant viral nucleic acids and vaccine containing same' [patent_app_type] => utility [patent_app_number] => 10/814689 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21321 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220816.pdf [firstpage_image] =>[orig_patent_app_number] => 10814689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856942 [patent_doc_number] => 07375202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Human virus causing severe acute respiratory syndrome (SARS) and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/808121 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 14 [patent_no_of_words] => 23876 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375202.pdf [firstpage_image] =>[orig_patent_app_number] => 10808121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 288899 [patent_doc_number] => 07547512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS)' [patent_app_type] => utility [patent_app_number] => 10/807807 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 106 [patent_figures_cnt] => 31 [patent_no_of_words] => 34004 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547512.pdf [firstpage_image] =>[orig_patent_app_number] => 10807807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056884 [patent_doc_number] => 20070059806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection' [patent_app_type] => utility [patent_app_number] => 10/546034 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27737 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059806.pdf [firstpage_image] =>[orig_patent_app_number] => 10546034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7261480 [patent_doc_number] => 20040241183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Human lymphocyte vaccine adjuvant' [patent_app_type] => new [patent_app_number] => 10/783259 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6967 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241183.pdf [firstpage_image] =>[orig_patent_app_number] => 10783259 [rel_patent_id] =>[rel_patent_doc_number] =>)